Join Our Penny Stock Newsletter

CytoDyn Inc. - CYDY

RSI %R Tweets Wolf Odds
73 -43 3 37.62%

Industry: Biotechnology / Sector: Healthcare

CYDY Chart

CYDY Quote

Prev Close: 0.6874
Open: 0.6880
Last Trade: 0.7
Change %: +1.830%
Change: +0.0126000
Volume: 149379
Avg Vol: 236622
Relative Vol: 0.63
Day Range: 0.6707 -0.7
52-Week Range: 0.460 - 0.840
Market Cap: 89.76M
Float: 142.52M
Shares Outstanding: 156.1M
Insider Owned: 10.84%
Institution Owned: 0.15%
Beta: -0.29
PE Ratio: 0.00
EPS: -0.25

CYDY Detailed Stats

RSI:72.76 %K:56.95 Wolf Odds: 37.62% Tweets Today:3 SMA14:0.6441
stochRSI:0.56 %D:55.58 Wolf Trend:0.53 Tweet Avg:5 Pivot Price:0.6902333
%R:-43.05 %B:0.68 Wolf 3-Day:0.39 Avg. Change 3-Day:-2.603% Resistance 1:0.7097667
MFI:54.81 Bandwidth:0.494788 Wolf 7-Day:0.47 Avg. Change 7-Day:+1.799% Resistance 2:0.7195333
WolfPeak:0.39 Vortex Indicator:0.39 Wolf 14-Day:0.45 Avg. Change 14-Day:+1.85% Support 1:0.6804667
ROC 7/14:12.0000/27.7605 Aroon Oscillator:85.7143 EOM:0.102832 Relative Vol:0.63 Support 2:0.6609333
RSI Alert:None WolfPeak Alert:None Vortex Alert:None Aroon Alert:None EOM Alert:None

Featured News *

CYDY News

CYDY Description

CytoDyn Inc., a clinical-stage biotechnology company, focuses on the clinical development and commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus (HIV) infection. Its lead product under development for HIV infection include PRO 140, a therapeutic anti-viral agent, which is in Phase IIb treatment substitution trial, Phase IIb extension study, Phase IIb/III pivotal trial, and Phase IIb/III investigative trial for HIV; and Phase II trial for graft-versus-host disease. The company is based in Vancouver, Washington.
Website: http://www.cytodyn.com

CYDY Comments

Recent CYDY Tweets

Powered by Ekonomys ver. 9

StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell

Information

Stock Wolf Twitter

Stock Wolf Facebook